GMO Capital Portfolio Q2 2026 Update: Tech, Healthcare, Financials Focus
Jeremy Grantham’s GMO Capital portfolio increased to $44 billion in the second quarter of 2026 from approximately $39 billion. The top holdings include Microsoft (MSFT), Lam Research (LRCX), Alphabet Inc. (GOOGL), Apple Inc. (AAPL), and Meta Platforms, which together account for about 25% of the portfolio. Microsoft remained GMO’s largest holding with a ~10% increase in value during the quarter. Significant additions were made to Thermo Fisher Scientific (TMO) and KLA Corporation (KLAC). Meanwhile, GMO reduced its positions in Lam Research, Alphabet, and U.S. Bancorp (USB), indicating active portfolio rebalancing. The firm’s strategy continues to emphasize technology, healthcare, and financials sectors with a strong conviction in core mega-cap tech stocks.
Tickers: $AAPL $GOOGL $KLAC $LRCX $META $MSFT $NVDA $TMO $USB